Volume 53, Issue 1, Pages (July 2010)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 1, Pages (July 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 51, Issue 3, Pages (September 2009)
Volume 134, Issue 3, Pages (March 2008)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The management of childhood liver diseases in adulthood
Volume 49, Issue 5, Pages (November 2008)
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Volume 55, Issue 1, Pages (July 2011)
Hepatic adenomatosis in liver cirrhosis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
The origin of cancer stem cells
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
The role of Epstein–Barr virus in acute and chronic hepatitis
Diagnostic Value of Albumin Gene Expression in Liver Tumors: Case Report and Review of the Literature  S. Vincent Rajkumar, M.D., Ronald L. Richardson,
The place of downstaging for hepatocellular carcinoma
Adult hepatoblastoma: Learning from children
ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable?  Jian Wu, Wei Bai,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 
Volume 65, Issue 2, Pages (August 2016)
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Why men are at higher risk for hepatocellular carcinoma?
Volume 126, Issue 5, Pages (May 2004)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 62, Issue 2, Pages (February 2015)
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 42, Issue 3, Pages (March 2005)
Volume 115, Issue 5, Pages (November 1998)
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Portal vein thrombosis, cirrhosis, and liver transplantation
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 4, Pages (April 2006)
Chetana Lim, Chady Salloum, Daniel Azoulay
Volume 50, Issue 3, Pages (March 2009)
Evolution of liver transplantation for hepatocellular carcinoma
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
Volume 63, Issue 1, Pages (July 2015)
Volume 42, Issue 6, Pages (June 2005)
Volume 61, Issue 5, Pages (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Vincenzo Mazzaferro, Andrea Pulvirenti, Jorgelina Coppa 
Volume 65, Issue 4, Pages (October 2016)
Statins: Old drugs as new therapy for liver diseases?
Pathogenesis of cholestatic hepatitis C
Volume 128, Issue 5, Pages (May 2005)
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Genetics of hepatocellular carcinoma: The next generation
Volume 67, Issue 5, Pages (November 2017)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 53, Issue 1, Pages 213-217 (July 2010) An adult male patient with multiple adenomas and a hepatocellular carcinoma: Mild Glycogen Storage Disease type Ia  David Cassiman, Louis Libbrecht, Chris Verslype, Wouter Meersseman, Roberto Troisi, Jessica Zucman-Rossi, Hans Van Vlierberghe  Journal of Hepatology  Volume 53, Issue 1, Pages 213-217 (July 2010) DOI: 10.1016/j.jhep.2010.03.002 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Several hepatocytes show swollen, vacuolated nuclei. Hepatocytes with such glycogenated nuclei are mainly located in the area surrounding the portal tract (PT) (long arrows). The cytoplasm of hepatocytes is frequently swollen and is pale with small clumps of eosinophilic material. This “plant-like” aspect is most pronounced in the area indicated by the small arrow and enlarged in the inset. Original magnification 400×. Journal of Hepatology 2010 53, 213-217DOI: (10.1016/j.jhep.2010.03.002) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 The adenomatous component of the multinodular lesion consists of trabecules of hepatocytes that show discrete nuclear atypia. The morphological features are consistent with a β-catenin activated adenoma. (A) Original magnification 200× and (B) same field at 400× magnification. Journal of Hepatology 2010 53, 213-217DOI: (10.1016/j.jhep.2010.03.002) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 3 In contrast to the adenomatous part, the areas that transformed into well-differentiated hepatocellular carcinoma show more distinct nuclear atypia and crowding due to an increased nucleo-cytoplasmic ratio and thickening of the trabecules. Original magnification 400×. Journal of Hepatology 2010 53, 213-217DOI: (10.1016/j.jhep.2010.03.002) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Mutation analysis (A) Both the adenomatous areas (A) as the parts that consist of malignant tumor (T) show diffuse and strong cytoplasmic staining for glutamine synthetase staining; (B) surrounding non-lesional tissue serving as an internal control only shows some staining in the area around the centrolobular vein (CV). Original magnification 200×. Journal of Hepatology 2010 53, 213-217DOI: (10.1016/j.jhep.2010.03.002) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions